Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Accumulated Expenses (2016 - 2025)

Bio-Techne has reported Accumulated Expenses over the past 16 years, most recently at $45.0 million for Q4 2025.

  • Quarterly results put Accumulated Expenses at $45.0 million for Q4 2025, up 63.48% from a year ago — trailing twelve months through Dec 2025 was $45.0 million (up 63.48% YoY), and the annual figure for FY2025 was $25.7 million, up 3.12%.
  • Accumulated Expenses for Q4 2025 was $45.0 million at Bio-Techne, up from $43.6 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for TECH hit a ceiling of $62.0 million in Q2 2022 and a floor of $15.3 million in Q2 2021.
  • Median Accumulated Expenses over the past 5 years was $30.0 million (2022), compared with a mean of $32.3 million.
  • Biggest five-year swings in Accumulated Expenses: surged 346.25% in 2021 and later crashed 53.78% in 2022.
  • Bio-Techne's Accumulated Expenses stood at $19.0 million in 2021, then decreased by 14.28% to $16.3 million in 2022, then grew by 5.41% to $17.2 million in 2023, then soared by 60.52% to $27.5 million in 2024, then soared by 63.48% to $45.0 million in 2025.
  • The last three reported values for Accumulated Expenses were $45.0 million (Q4 2025), $43.6 million (Q3 2025), and $25.7 million (Q2 2025) per Business Quant data.